THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $155.53 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2024-11-20
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2024-09-30 was $67.90K, a 81.01% increase year-over-year.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2024-06-30 was $43.17K, a 22.33% increase year-over-year.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2024-03-31 was $44.45K, a 0.63% decline year-over-year.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-12-31 was $30.75K, a 2.34% increase year-over-year.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $148.29K, a 12.49% decline from fiscal 2022.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $169.45K, a 10.33% decline from fiscal 2021.
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $188.98K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $67.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $111.08K derived: sum of 2 quarters · filed 2024-11-20 | $155.53K 10-Q · filed 2024-11-20 | $186.28K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | $43.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $87.63K 10-Q · filed 2024-08-19 | $118.38K derived: sum of 3 quarters · filed 2024-08-19 | $155.89K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-03-31 | $44.45K 10-Q · filed 2024-05-30 | $75.20K derived: sum of 2 quarters · filed 2024-05-30 | $112.72K derived: sum of 3 quarters · filed 2024-11-20 | $148.01K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-12-31 | $30.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $68.26K derived: sum of 2 quarters · filed 2024-11-20 | $103.55K derived: sum of 3 quarters · filed 2024-11-20 | $148.29K 10-K · filed 2024-04-17 |
| 2023-09-30 | $37.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $72.80K derived: sum of 2 quarters · filed 2024-11-20 | $117.54K 10-Q · filed 2024-11-20 | $147.58K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-06-30 | $35.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $80.03K 10-Q · filed 2024-08-19 | $110.07K derived: sum of 3 quarters · filed 2024-08-19 | $161.58K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $44.73K 10-Q · filed 2024-05-30 | $74.78K derived: sum of 2 quarters · filed 2024-05-30 | $126.29K derived: sum of 3 quarters · filed 2024-05-30 | $169.94K derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-12-31 | $30.05K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $81.55K derived: sum of 2 quarters · filed 2024-04-17 | $125.21K derived: sum of 3 quarters · filed 2024-04-17 | $169.45K 10-K · filed 2024-04-17 |
| 2022-09-30 | $51.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $95.16K derived: sum of 2 quarters · filed 2023-11-14 | $139.41K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $43.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $87.90K 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $44.24K 10-Q · filed 2023-05-16 | |||
| 2021-12-31 | $188.98K 10-K · filed 2023-03-29 |